medical conferences |
||||||
News for 25-May-25 Source: MedicineNet High Blood Pressure General Source: MedicineNet Diabetes General Source: MedicineNet High Blood Pressure General Source: MedicineNet High Blood Pressure General Source: MedicineNet Diabetes General Source: MedicineNet Diabetes General Source: MedicineNet High Blood Pressure General Source: MedicineNet High Blood Pressure General Source: MedicineNet High Blood Pressure General Source: MedicineNet Diabetes General
|
The Best medical conferences websiteAll the medical conferences information you need to know about is right
here. Presented and researched by http://www.mdnewscast.net. We've searched
the information super highway far and wide to provide you with the
best medical conferences site on the internet today. The links below will
assist you in your efforts to find the information that you are looking
for about
medical conferences
As the Internet grows and expands medical conferences traders gain more experience in offering products for sale. One of the big advantages that online medical conferences traders have over shop front medical conferences stores is that the capital costs are significantly less. A traditional medical conferences outlet would need to employ staff, runs lots of medical conferences related advertising and pay rents or taxes. When a medical conferences business is placed online these overheads are significantly reduced. medical conferences
One of the major downsides of chat rooms is that ignorant people may pose as experts. If someone states they are a medical conferences expert then how can this be verified? If you have expertise in the field of medical conferences then you'll be able to verify their credentials. It's a matter of picking the expert from the fake. Talking of fakes it's sad to see so many medical conferences fakes bombarding email servers with unsolicited spam emails trying to sell medical conferences. Spam is a great threat to how the Internet works. Our website does not contain any email addresses for this reason. If you visit the medical conferences linked site above you will find that they treat your email address with great respect. Talking online real people who are very knowledgeable about medical conferences can be like attending a real medical conferences convention ... except that there are no airfares or accommodation expenses. Treating Chronic Mutational Hepatitis B with Chinese Medicine Vitalliver (Vigconic Suppositories) by: ZHANG GUAN HUA, LIANG CHAO, ZHENG WAN PIN
Treating chronic mutational hepatitis B with Chinese medicine Vitalliver (Vigconic suppositories)
Research Method: Quantitative determination by contrasting HBV-DNA of cases before and after the treatment. Number of cases: 25 (n) Case Selection: Between the age of 16 and 65, in accordance with the diagnosis standards pf chronic Hepatitis B, with negative e antigen and positive e antibody, HBV-DNA > 1×104 cp/mL. Detection Method: All the blood samples are detected by Sichuan Clinical Detection Center; PCR-ELISA quantitative determination is used within detection range of 1×104 - 1×107-8, HBV-DNA, unit of measurement is cp/mL. Direction Plan: one suppository provided by Vigconic (International) Ltd. Bid. The course of treatment is six months, the tracing observation after withdrawal lasts six months. Observation index:
Criterion of Therapeutic Effect:
HBV-DNA volume 1×104 cp/mL: 2/25 (8%) Among the results of lasting response, 16 blood serum samples are detected through fluorimetric quantitative determination PCR by the instruments of PE.USD, H-7700 in the second attached hospital of Guangzhou Medical College. The result is in accordance with that in Sichuan Clinical Testing Center. (8 cases among it < 1×102 cp/mL). The testing range of this testing method is 1×102 - 1×107-8 cp/mL. Conclusion The reason for the repeatedly abnormal liver function of Chronic Hepatitis B (CHB) patients lies in the repeatedly duplication of HBV after infection, which leads to fibrosis of liver, then cirrhosis and liver cancer. It is commonly accepted that if CHB shows the transformation of HBeAg/Anti-HBe, HBV-DNA becoming negative, liver function returning to normal state, the disease is relieved. However, parts of patients with the transformation of HBeAg/Anti-HBe still remain positive in HBV-DNA and the pathological change in the liver continues. Because HBV-DNA occurs promoter mutation in the anterior C section (1896 necleoside G-A variation) or in the C section (1762 nucleoside T variation, 1764 G-A variation), HBeAg cannot come into being. Therefore, the HBeAg in the patient's blood cannot be detected, while the virus can keep on duplicating and fixing itself. Through sequential assay of nucleic acid, it proves that promoter mutation appears in 30%-60% of HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section. In some provinces and cities of the People of China, the percentage of promoter mutation appears in HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section is from 17.6% to 78.9%. Eight out of the 25 cases of our observation go through the sequential assay of nucleic acid carried out by the Department of Microbiology of the University of Hong Kong. It all proves to have HBV-DNA mutation. The chronic mutational Hepatitis B is infectious and apt to cause cirrhosis and liver cancer since the present medicines of antivirus and immuno-modulator do not produce the expected therapeutic effects. Vitalliver suppository is made up from a formula of Chinese herbs, including Ginseng, Deer Horn, Cordyceps, Radix Astragali, Frudctus Cnidii, Semen Cuscutae, etc. The formula is mainly for strengthening the body resistant and primarily for reinforcing Kidney Qi, which produces good therapeutic effects in treating chronic mutational Hepatitis B. The mechanism is probably that through the regulating of immune system, the duplication of virus is inhibited and meanwhile the liver is protected, so it can produce a lasting therapeutic effect. No adverse reaction and severe accident happens during clinical observation, so it is safe for using. Vitalliver is bringing hopes to the treatment of chronic mutational Hepatitis B. * The second stage of clinical trial would be carrying out by the Microbiology Department of the University of Hong Kong and Chengdu University of Traditional Chinese Medicine. For more information, please visit: http://www.vigconic.com
|
|||||
http://www.medmeet.com/ |
Medical Newscast Xbox online games Talk On The Net |